Sharon Mates Intra Cellular Therapies, Inc. (ITCI) insider trading activity

ITCI Quotes by TradingView

Sharon Mates is Chairman and CEO of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 0 shares of ITCI, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2021, when has been sold 34,341 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Sharon Mates Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2021
BUY
Exercise of conversion of derivative security
-
34,341 Added 2.82%
1,181,733 Common Stock
Dec 18 2020
BUY
Exercise of conversion of derivative security
$93,160 $2.74 p/Share
34,000 Added 2.88%
1,147,392 Common Stock
Nov 10 2020
SELL
Open market or private sale
$1,322,500 $26.45 p/Share
50,000 Reduced 4.3%
1,113,392 Common Stock
Nov 04 2020
SELL
Open market or private sale
$1,250,000 $25.0 p/Share
50,000 Reduced 4.12%
1,163,392 Common Stock
SM

Sharon Mates

Chairman and CEO
New York, NY

Track Institutional and Insider Activities on ITCI

Follow Intra-Cellular Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

News

Receive news related to Intra-Cellular Therapies, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITCI